About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The broad purpose of the Epidemiology and Public Health research group is contributing to increase the available scientific evidence regarding preventive interventions, to promote health, and prevent morbidity and mortality from major diseases. Our group uses epidemiological methods to study etiology, surveillance, and efficacy of these interventions. We are primarily focused on epidemiology and prevention of infectious diseases, in both individual and population levels. Main lines of research:
PMID: 34826619 Journal: CLINICAL MICROBIOLOGY AND INFECTION Year: 2022 Reference: Clin Microbiol Infect. 2022 Mar;28(3):315-318. doi: 10.1016/j.cmi.2021.11.015. Epub 2021 Nov 24. Impact factor: Publication type: Letter or abstract Authors: Anto, Josep M; Anton, Juana Diez; Bassat, Quique; Bassat, Quique; Blanco, Julia; Blanco, Julia; Brotons, Carles; Brotons, Carlos; Campins, Magda; de Sanjose, Silvia et al. DOI: 10.1016/j.cmi.2021.11.015
PMID: 35051890 Journal: SEMINARS IN ARTHRITIS AND RHEUMATISM Year: 2022 Reference: Semin Arthritis Rheum. 2022 Apr;53:151940. doi: 10.1016/j.semarthrit.2021.12.008. Epub 2021 Dec 31. Impact factor: Publication type: Paper in international publication Authors: Alvarado-Cardenas, M; Gil-Vila, Albert; Martinez-Gomez, X; Pinal-Fernandez, Iago; Selva-O'Callaghan, Albert; Simo-Perdigo, M; Trallero-Araguas, Ernesto et al. DOI: 10.1016/j.semarthrit.2021.12.008
PMID: 33609298 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2022 Reference: Eur J Neurol. 2022 Apr;29(4):1075-1081. doi: 10.1111/ene.14782. Epub 2021 Mar 17. Impact factor: Publication type: Paper in international publication Authors: Arrambide, Georgina; Auger, Cristina; Carbonell-Mirabent, Pere; Castillo, Joaquin; Comabella Lopez, Manuel; Galan, Ingrid; Midaglia, Luciana; Montalban, Xavier; Mulero, Patricia; Nos, Carlos et al. DOI: 10.1111/ene.14782
PMID: 35196927 Journal: Multiple Sclerosis Journal Year: 2022 Reference: Mult Scler. 2022 Aug;28(9):1424-1456. doi: 10.1177/13524585211069068. Epub 2022 Feb 23. Impact factor: Publication type: Review in international publication Authors: Abboud, Hesham; Achiron, Anat; Amato, Maria Pia; Bellinvia, Angelo; Boyko, Alexey; Casanova, Jean-Laurent; Clifford, David; Derfuss, Tobias; Di Pauli, Franziska; Dobson, Ruth et al. DOI: 10.1177/13524585211069068
PMID: 33709979 Journal: CURRENT OPINION IN NEUROLOGY Year: 2021 Reference: Curr Opin Neurol. 2021 Jun 1;34(3):322-328. doi: 10.1097/WCO.0000000000000929. Impact factor: Publication type: Review in international publication Authors: Ascherio, Alberto; Lebrun-Frenay, Christine; Otero-Romero, Susana et al. DOI: 10.1097/WCO.0000000000000929
PMID: 32229130 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2021 Reference: Enferm Infecc Microbiol Clin. 2021 Mar;39(3):134-138. doi: 10.1016/j.eimc.2020.02.015. Epub 2020 Mar 27. Impact factor: Publication type: Paper in national publication Authors: Alonso Garcia, Laura; Barnes-Mayolas, Meritxell; Castellnou Asens, Ivette; Castilla Fernandez, Yolanda; Estrella Barcelo, Maria; Fernandez Polo, Aurora; Fernandez-Polo, Aurora; Lopez Fernandez, Sergio; Melendo Perez, Susana; Melendo, Susana et al. DOI: 10.1016/j.eimc.2020.02.015
PMID: 33576860 Journal: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY Year: 2021 Reference: Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1993-2003. doi: 10.1007/s00417-021-05093-4. Epub 2021 Feb 12. Impact factor: Publication type: Paper in international publication Authors: Abraldes, Maximino; Bures, Anniken; Gallego-Pinazo, Roberto; Gutierrez-Sanchez, Estanislao; Olenik, Andrea; Otero-Romero, Susana; Pastor, Salvador; Ruiz-Medrano, Jorge; Salinas, Cecilia; Zapata, Miguel A et al. DOI: 10.1007/s00417-021-05093-4
PMID: 33543657 Journal: Expert Review of Clinical Immunology Year: 2021 Reference: Expert Rev Clin Immunol. 2021 Mar;17(3):285-300. doi: 10.1080/1744666X.2021.1886924. Epub 2021 Mar 8. Impact factor: Publication type: Paper in international publication Authors: Otero-Romero, Susana; Sanchez-Montalva, Adrian; Vidal-Jordana, Angela et al. DOI: 10.1080/1744666X.2021.1886924
PMID: 32574139 Journal: EMERGING INFECTIOUS DISEASES Year: 2020 Reference: Emerg Infect Dis. 2020 Sep;26(9). doi: 10.3201/eid2609.202603. Epub 2020 Jun 23. Impact factor: 6.259 Publication type: Paper in international publication Authors: Abadias, Maria Jose, Roman, Antonio, Pumarola, Tomas, Campins, Magda, Almirante, Benito, Selvi, Marta, Martin, Elisabet, Anton, Andres, Esperalba, Juliana, Borras-Bermejo, Blanca et al. DOI: 10.3201/eid2609.202603
PMID: 30509614 Journal: MEDICINA CLINICA Year: 2019 Reference: Med Clin (Barc). 2019 Apr 18;152(8):317-323. doi: 10.1016/j.medcli.2018.10.013. Epub 2018 Dec 1. Impact factor: 1.277 Publication type: Review in national publication Authors: Campins Marti, Magda, Borras Bermejo, Blanca, Armadans Gil, Lluis et al. DOI: 10.1016/j.medcli.2018.10.013
PMID: 30926297 Journal: VACCINE Year: 2019 Reference: Vaccine. 2019 Apr 24;37(18):2470-2476. doi: 10.1016/j.vaccine.2019.03.046. Epub 2019 Mar 27. Impact factor: 3.269 Publication type: Paper in international publication Authors: Andres, Cristina, Peremiquel-Trillas, Paula, Gimferrer, Laura, Pinana, Maria, Codina, Maria Gema, Rodrigo-Pendas, Jose Angel, Campins-Marti, Magda, Carmen Martin, Maria, Fuentes, Francisco, Rubio, Susana et al. DOI: 10.1016/j.vaccine.2019.03.046
PMID: 30860397 Journal: Future Microbiology Year: 2019 Reference: Future Microbiol. 2019 Mar;14:373-381. doi: 10.2217/fmb-2018-0261. Epub 2019 Mar 12. Impact factor: 2.746 Publication type: Paper in international publication Authors: Pinana, Maria, Andres, Cristina, Rodrigo-Pendas, Jose A, Peremiquel-Trillas, Paula, Codina, Maria G, Carmen Martin, Maria Del, Esperalba, Juliana, Fuentes, Francisco, Rubio, Susana, Campins-Marti, Magda et al. DOI: 10.2217/fmb-2018-0261
PMID: 30553564 Journal: ENVIRONMENT INTERNATIONAL Year: 2019 Reference: Environ Int. 2019 Jan;122:389-399. doi: 10.1016/j.envint.2018.12.007. Epub 2018 Dec 13. Impact factor: 7.943 Publication type: Paper in international publication Authors: Capelo, Rocio, Molina de la Torre, Antonio J, Salas Trejo, Dolores, Fernandez-Tardon, Guillermo, Lope, Virginia, Jimenez-Moleon, Jose J, Marcos-Gragera, Rafael, Dierssen-Sotos, Trinidad, Azpiri, Mikel, Munoz, Montse et al. DOI: 10.1016/j.envint.2018.12.007
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.
El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.
